NO323687B1 - Anvendelse av benzofenantridinalkaloider som fôrtilsetningsstoff. - Google Patents
Anvendelse av benzofenantridinalkaloider som fôrtilsetningsstoff. Download PDFInfo
- Publication number
- NO323687B1 NO323687B1 NO20031196A NO20031196A NO323687B1 NO 323687 B1 NO323687 B1 NO 323687B1 NO 20031196 A NO20031196 A NO 20031196A NO 20031196 A NO20031196 A NO 20031196A NO 323687 B1 NO323687 B1 NO 323687B1
- Authority
- NO
- Norway
- Prior art keywords
- amino acids
- benzophenanthridine alkaloids
- alkaloids
- aromatic amino
- sheep
- Prior art date
Links
- 229930015421 benzophenanthridine alkaloid Natural products 0.000 title claims description 32
- 150000008622 benzophenanthridines Chemical class 0.000 title claims description 32
- 239000003674 animal food additive Substances 0.000 title description 4
- -1 aromatic amino acids Chemical class 0.000 claims description 23
- 229930013930 alkaloid Natural products 0.000 claims description 22
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 claims description 16
- 241000218180 Papaveraceae Species 0.000 claims description 16
- 241001494479 Pecora Species 0.000 claims description 16
- ZFRKQXVRDFCRJG-UHFFFAOYSA-N skatole Chemical compound C1=CC=C2C(C)=CNC2=C1 ZFRKQXVRDFCRJG-UHFFFAOYSA-N 0.000 claims description 14
- 230000015556 catabolic process Effects 0.000 claims description 13
- 241000196324 Embryophyta Species 0.000 claims description 12
- 150000003797 alkaloid derivatives Chemical class 0.000 claims description 12
- 239000000654 additive Substances 0.000 claims description 11
- 239000003814 drug Substances 0.000 claims description 10
- 230000002255 enzymatic effect Effects 0.000 claims description 8
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 claims description 8
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 claims description 8
- 239000000470 constituent Substances 0.000 claims description 7
- 230000002401 inhibitory effect Effects 0.000 claims description 7
- 239000000463 material Substances 0.000 claims description 7
- 102000004169 proteins and genes Human genes 0.000 claims description 7
- 108090000623 proteins and genes Proteins 0.000 claims description 7
- 229940074386 skatole Drugs 0.000 claims description 7
- 206010061218 Inflammation Diseases 0.000 claims description 5
- 230000004054 inflammatory process Effects 0.000 claims description 5
- 230000000968 intestinal effect Effects 0.000 claims description 5
- 238000004519 manufacturing process Methods 0.000 claims description 5
- 230000000996 additive effect Effects 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 4
- 230000037354 amino acid metabolism Effects 0.000 claims description 3
- 239000000284 extract Substances 0.000 claims description 3
- 210000003608 fece Anatomy 0.000 claims description 3
- 210000001035 gastrointestinal tract Anatomy 0.000 claims description 3
- 244000144972 livestock Species 0.000 claims description 3
- 239000010871 livestock manure Substances 0.000 claims description 3
- 229940079593 drug Drugs 0.000 claims description 2
- 239000002243 precursor Substances 0.000 claims description 2
- 235000001014 amino acid Nutrition 0.000 description 26
- INVGWHRKADIJHF-UHFFFAOYSA-N Sanguinarin Chemical compound C1=C2OCOC2=CC2=C3[N+](C)=CC4=C(OCO5)C5=CC=C4C3=CC=C21 INVGWHRKADIJHF-UHFFFAOYSA-N 0.000 description 16
- 241001465754 Metazoa Species 0.000 description 15
- 102000003823 Aromatic-L-amino-acid decarboxylases Human genes 0.000 description 14
- 108090000121 Aromatic-L-amino-acid decarboxylases Proteins 0.000 description 14
- 230000002829 reductive effect Effects 0.000 description 9
- 229940084560 sanguinarine Drugs 0.000 description 9
- FCEXWTOTHXCQCQ-UHFFFAOYSA-N Ethoxydihydrosanguinarine Natural products C12=CC=C3OCOC3=C2C(OCC)N(C)C(C2=C3)=C1C=CC2=CC1=C3OCO1 FCEXWTOTHXCQCQ-UHFFFAOYSA-N 0.000 description 8
- 239000003795 chemical substances by application Substances 0.000 description 8
- YZRQUTZNTDAYPJ-UHFFFAOYSA-N sanguinarine pseudobase Natural products C1=C2OCOC2=CC2=C3N(C)C(O)C4=C(OCO5)C5=CC=C4C3=CC=C21 YZRQUTZNTDAYPJ-UHFFFAOYSA-N 0.000 description 8
- 150000001413 amino acids Chemical class 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 235000018102 proteins Nutrition 0.000 description 6
- 102000004190 Enzymes Human genes 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- WEEFNMFMNMASJY-UHFFFAOYSA-M 1,2-dimethoxy-12-methyl-[1,3]benzodioxolo[5,6-c]phenanthridin-12-ium;chloride Chemical compound [Cl-].C1=C2OCOC2=CC2=CC=C3C4=CC=C(OC)C(OC)=C4C=[N+](C)C3=C21 WEEFNMFMNMASJY-UHFFFAOYSA-M 0.000 description 4
- LLEJIEBFSOEYIV-UHFFFAOYSA-N Chelerythrine Natural products C1=C2OCOC2=CC2=CC=C3C4=CC=C(OC)C(OC)=C4C=[N+](C)C3=C21 LLEJIEBFSOEYIV-UHFFFAOYSA-N 0.000 description 4
- RATMHCJTVBHJSU-UHFFFAOYSA-N Dihydrochelerythrine Natural products C1=C2OCOC2=CC2=C(N(C)C(O)C=3C4=CC=C(C=3OC)OC)C4=CC=C21 RATMHCJTVBHJSU-UHFFFAOYSA-N 0.000 description 4
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 4
- 241000282887 Suidae Species 0.000 description 4
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 4
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 4
- 235000020776 essential amino acid Nutrition 0.000 description 4
- 239000003797 essential amino acid Substances 0.000 description 4
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 description 4
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 3
- 102000002322 Egg Proteins Human genes 0.000 description 3
- 108010000912 Egg Proteins Proteins 0.000 description 3
- 244000001385 Sanguinaria canadensis Species 0.000 description 3
- 235000014103 egg white Nutrition 0.000 description 3
- 210000000969 egg white Anatomy 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 210000004347 intestinal mucosa Anatomy 0.000 description 3
- 210000000936 intestine Anatomy 0.000 description 3
- 235000020997 lean meat Nutrition 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 235000013336 milk Nutrition 0.000 description 3
- 239000008267 milk Substances 0.000 description 3
- 210000004080 milk Anatomy 0.000 description 3
- SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 description 2
- 241000224483 Coccidia Species 0.000 description 2
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- 208000018737 Parkinson disease Diseases 0.000 description 2
- 241000607142 Salmonella Species 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- UCTWMZQNUQWSLP-UHFFFAOYSA-N adrenaline Chemical compound CNCC(O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-UHFFFAOYSA-N 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 229960003638 dopamine Drugs 0.000 description 2
- 235000020774 essential nutrients Nutrition 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000002757 inflammatory effect Effects 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 229960002748 norepinephrine Drugs 0.000 description 2
- SFLSHLFXELFNJZ-UHFFFAOYSA-N norepinephrine Natural products NCC(O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-UHFFFAOYSA-N 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 244000045947 parasite Species 0.000 description 2
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 2
- 229940076279 serotonin Drugs 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 241001233914 Chelidonium majus Species 0.000 description 1
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- 240000007849 Macleaya cordata Species 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 241000282849 Ruminantia Species 0.000 description 1
- QXVJDCUNQFSDBQ-UHFFFAOYSA-N Sanguilutine Chemical compound C1=C(OC)C(OC)=C2C=[N+](C)C3=C(C=C(C(OC)=C4)OC)C4=CC=C3C2=C1OC QXVJDCUNQFSDBQ-UHFFFAOYSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 235000011941 Tilia x europaea Nutrition 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- TVIUWRVHXUBTAZ-UHFFFAOYSA-N [Pb].N1C=C(C)C2=CC=CC=C12 Chemical compound [Pb].N1C=C(C)C2=CC=CC=C12 TVIUWRVHXUBTAZ-UHFFFAOYSA-N 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 235000019728 animal nutrition Nutrition 0.000 description 1
- 235000019463 artificial additive Nutrition 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- QRCWKBAFKDYSFR-UHFFFAOYSA-N chelirubine Natural products COc1cc2cc3OCOc3cc2c4N(C)C(O)c5c6OCOc6ccc5c14 QRCWKBAFKDYSFR-UHFFFAOYSA-N 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 235000013330 chicken meat Nutrition 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 230000007515 enzymatic degradation Effects 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000011868 grain product Nutrition 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 239000004571 lime Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000002940 repellent Effects 0.000 description 1
- 239000005871 repellent Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000003307 slaughter Methods 0.000 description 1
- 235000002639 sodium chloride Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- 239000005526 vasoconstrictor agent Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 230000036642 wellbeing Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/116—Heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/30—Feeding-stuffs specially adapted for particular animals for swines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Polymers & Plastics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Animal Husbandry (AREA)
- Food Science & Technology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Fodder In General (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AT0157900A AT500455B1 (de) | 2000-09-15 | 2000-09-15 | Verwendung von benzophenanthridinalkaloiden als futteradditiv |
| PCT/IB2001/002487 WO2002021932A2 (de) | 2000-09-15 | 2001-09-14 | Futtermittel, futterzusatzmittel und heilmittel gegen darmentzündung |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO20031196D0 NO20031196D0 (no) | 2003-03-14 |
| NO20031196L NO20031196L (no) | 2003-05-15 |
| NO323687B1 true NO323687B1 (no) | 2007-06-25 |
Family
ID=3688371
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20031196A NO323687B1 (no) | 2000-09-15 | 2003-03-14 | Anvendelse av benzofenantridinalkaloider som fôrtilsetningsstoff. |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US20030190344A1 (cs) |
| EP (1) | EP1317188B2 (cs) |
| JP (1) | JP2004508059A (cs) |
| AT (1) | AT500455B1 (cs) |
| AU (1) | AU2002222354A1 (cs) |
| BG (1) | BG107626A (cs) |
| CA (1) | CA2422250A1 (cs) |
| CZ (1) | CZ299208B6 (cs) |
| DE (1) | DE50104706D1 (cs) |
| EE (1) | EE200300101A (cs) |
| ES (1) | ES2233706T5 (cs) |
| HR (1) | HRP20030193A2 (cs) |
| HU (1) | HUP0302433A3 (cs) |
| NO (1) | NO323687B1 (cs) |
| PL (1) | PL365902A1 (cs) |
| PT (1) | PT1317188E (cs) |
| RO (1) | RO121630B1 (cs) |
| SI (1) | SI21164B (cs) |
| SK (1) | SK285504B6 (cs) |
| WO (1) | WO2002021932A2 (cs) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AT500455B1 (de) † | 2000-09-15 | 2007-08-15 | Roth Hermann Dr | Verwendung von benzophenanthridinalkaloiden als futteradditiv |
| AT500589B1 (de) * | 2004-05-19 | 2009-08-15 | Roth Hermann Dr | Alkaloidhaltiges futtermittel bzw. futtermittelzusatz |
| EP1882473A1 (en) * | 2006-07-28 | 2008-01-30 | Indena S.P.A. | Use of anthocyanosides to prepare formulations for the treatment of mucositis induced by antitumoral drugs |
| AT504440B1 (de) | 2006-11-13 | 2012-03-15 | Neufeld Klaus | Ballaststoff |
| AT506498B1 (de) * | 2008-02-25 | 2011-02-15 | Roth Hermann Dr | Verfahren zur fermentation von biomasse |
| AT509728B1 (de) | 2010-04-15 | 2012-05-15 | Neufeld Klaus | Verwendung eines alkaloidhältigen pflanzenextraktes beziehungsweise pflanzenmaterials als tierfutterzusatz |
| JP5385446B2 (ja) * | 2012-11-12 | 2014-01-08 | 国立大学法人東京海洋大学 | 魚類のタンパク質節約を目的とした飼料 |
| JP6253964B2 (ja) * | 2013-11-29 | 2017-12-27 | 日本ニュートリション株式会社 | 牛乳の乳質改善剤および乳質改善方法 |
| AT515336A1 (de) * | 2014-02-03 | 2015-08-15 | Roth Hermann Dr | Vermeidung oxidativer Prozesse und oxidativem Stress |
| WO2016056520A1 (ja) * | 2014-10-06 | 2016-04-14 | 扶桑化学工業株式会社 | 水中動物用飼料、水中動物用発育向上剤、および、それらを用いた養殖魚の飼育方法 |
| CN104351534B (zh) * | 2014-11-03 | 2017-09-12 | 广东恒兴饲料实业股份有限公司 | 一种陆川猪用促生长饲料添加剂预混料及应用方法 |
| US20170095467A1 (en) * | 2015-10-01 | 2017-04-06 | Rhizofeed, LLC | Encapsulation of isoquinoline alkaloids |
| BR112019000815A2 (pt) * | 2017-04-04 | 2019-11-05 | Roth Hermann | alimento para animais ou suplemento alimentar para animais e método para diminuir a quantidade de proteína que precisa ser alimentada a um animal durante a aplicação de um agonista beta adrenérgico para permitir que o agonista beta adrenérgico se torne fisiologicamente eficaz |
| CN107683970A (zh) * | 2017-09-21 | 2018-02-13 | 香格里拉市利众种植农民专业合作社 | 藏香猪育肥饲料及其制备方法 |
| CN107667969A (zh) * | 2017-10-21 | 2018-02-09 | 赵三存 | 一种提高猪肉瘦肉率的育肥方法 |
| CN107568458A (zh) * | 2017-10-24 | 2018-01-12 | 山西大禹生物工程股份有限公司 | 一种免疫促进饲料添加剂 |
| CN108567059B (zh) * | 2018-05-09 | 2021-09-07 | 湖南弘康生态农业科技发展股份有限公司 | 一种猪饲料及其制备方法 |
| EP3851116A1 (de) * | 2020-01-20 | 2021-07-21 | Phytobiotics Futterzusatzstoffe GmbH | Substanzkombination mit isochinolinalkaloiden und kokzidiostatikum oder kokzidioseimpfmittel |
| CN113480552B (zh) * | 2021-06-04 | 2022-05-10 | 中国农业科学院北京畜牧兽医研究所 | 一种化合物及其在改善动物瘤胃微生物发酵中的用途 |
| EP4241572A1 (de) | 2022-03-11 | 2023-09-13 | Phytobiotics Futterzusatzstoffe GmbH | Tierfutter oder tierfutterzusatz mit canadin und/oder canadin-derivat |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4335110A (en) * | 1979-08-23 | 1982-06-15 | Orewa Inc. | Pharmaceutical compositions of sanguinaria galangal and zinc chloride |
| AU548560B2 (en) * | 1980-05-20 | 1985-12-19 | Vipont Laboratories Inc. | Benzophenanthridine alkaloids as antimicrobial agents |
| US5175000A (en) † | 1987-06-30 | 1992-12-29 | Vipont Pharmaceutical, Inc. | Free amine benzophenanthridine alkaloid compositions |
| JP2599158B2 (ja) * | 1987-12-26 | 1997-04-09 | 日清製粉株式会社 | 家畜のカンピロバクター・ジェジュニ感染症の予防及び治療剤 |
| JP2578488B2 (ja) * | 1988-03-04 | 1997-02-05 | 協和醗酵工業株式会社 | アミノ酸の製造法 |
| AT403873B (de) * | 1992-02-21 | 1998-06-25 | Neufeld Klaus Dr | Tierfutter zur leistungssteigerung |
| NL1008054C2 (nl) * | 1998-01-16 | 1999-07-19 | Nl Zuivelonderzoek Inst | Werkwijze voor het produceren van alanine, alsmede hierbij toegepaste micro-organismen en recombinant DNA moleculen. |
| AT500455B1 (de) † | 2000-09-15 | 2007-08-15 | Roth Hermann Dr | Verwendung von benzophenanthridinalkaloiden als futteradditiv |
-
2000
- 2000-09-15 AT AT0157900A patent/AT500455B1/de not_active IP Right Cessation
-
2001
- 2001-09-14 AU AU2002222354A patent/AU2002222354A1/en not_active Abandoned
- 2001-09-14 CA CA002422250A patent/CA2422250A1/en not_active Abandoned
- 2001-09-14 WO PCT/IB2001/002487 patent/WO2002021932A2/de active IP Right Grant
- 2001-09-14 EE EEP200300101A patent/EE200300101A/xx unknown
- 2001-09-14 PL PL01365902A patent/PL365902A1/xx not_active IP Right Cessation
- 2001-09-14 HU HU0302433A patent/HUP0302433A3/hu unknown
- 2001-09-14 SI SI200120056A patent/SI21164B/sl not_active IP Right Cessation
- 2001-09-14 SK SK300-2003A patent/SK285504B6/sk unknown
- 2001-09-14 RO ROA200300226A patent/RO121630B1/ro unknown
- 2001-09-14 PT PT01984622T patent/PT1317188E/pt unknown
- 2001-09-14 DE DE50104706T patent/DE50104706D1/de not_active Expired - Lifetime
- 2001-09-14 HR HR20030193A patent/HRP20030193A2/hr not_active Application Discontinuation
- 2001-09-14 JP JP2002526198A patent/JP2004508059A/ja active Pending
- 2001-09-14 ES ES01984622T patent/ES2233706T5/es not_active Expired - Lifetime
- 2001-09-14 CZ CZ20030714A patent/CZ299208B6/cs not_active IP Right Cessation
- 2001-09-14 EP EP01984622A patent/EP1317188B2/de not_active Expired - Lifetime
- 2001-09-14 US US10/380,447 patent/US20030190344A1/en not_active Abandoned
-
2003
- 2003-03-11 BG BG107626A patent/BG107626A/bg unknown
- 2003-03-14 NO NO20031196A patent/NO323687B1/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BG107626A (bg) | 2003-11-28 |
| DE50104706D1 (de) | 2005-01-05 |
| NO20031196L (no) | 2003-05-15 |
| WO2002021932A3 (de) | 2002-10-17 |
| AT500455B1 (de) | 2007-08-15 |
| JP2004508059A (ja) | 2004-03-18 |
| AU2002222354A1 (en) | 2002-03-26 |
| WO2002021932A2 (de) | 2002-03-21 |
| EE200300101A (et) | 2005-02-15 |
| PL365902A1 (en) | 2005-01-10 |
| SK3002003A3 (en) | 2003-08-05 |
| HUP0302433A2 (hu) | 2003-10-28 |
| ES2233706T5 (es) | 2008-12-01 |
| PT1317188E (pt) | 2005-04-29 |
| HUP0302433A3 (en) | 2006-02-28 |
| SK285504B6 (sk) | 2007-03-01 |
| SI21164A (sl) | 2003-10-31 |
| NO20031196D0 (no) | 2003-03-14 |
| CZ299208B6 (cs) | 2008-05-21 |
| ES2233706T3 (es) | 2005-06-16 |
| RO121630B1 (ro) | 2008-01-30 |
| AT500455A1 (de) | 2005-12-15 |
| EP1317188A2 (de) | 2003-06-11 |
| SI21164B (sl) | 2005-10-31 |
| US20030190344A1 (en) | 2003-10-09 |
| EP1317188B1 (de) | 2004-12-01 |
| HRP20030193A2 (en) | 2005-10-31 |
| CA2422250A1 (en) | 2003-03-14 |
| EP1317188B2 (de) | 2008-06-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO323687B1 (no) | Anvendelse av benzofenantridinalkaloider som fôrtilsetningsstoff. | |
| Carabaño Luengo et al. | New concepts and objectives for protein-amino acid nutrition in rabbits: a review | |
| TWI499380B (zh) | Livestock feed additives and livestock feed composition | |
| CA2373499C (en) | Use of creatine as feed additive | |
| BR122018076097B1 (pt) | uso de ao menos um dentre líquido de casca de castanha de caju, líquido de casca de castanha de caju tratado por calor, ácido anacárdico, cardanol e cardol | |
| Conde-Aguilera et al. | The amino acid composition of tissue protein is affected by the total sulfur amino acid supply in growing pigs | |
| NO335457B1 (no) | Fôr eller fôrtilsetning inneholdende et alkaloid, samt anvendelse | |
| US20250090612A1 (en) | Feed additive compositions and methods of use | |
| Zhao et al. | Comparative study on the utilization of different methionine sources by channel catfish, Ictalurus punctatus (Rafinesque, 1818) | |
| TWI851662B (zh) | 類黃酮及動物健康及生產能力 | |
| JP7167287B2 (ja) | 圧縮成型製剤 | |
| Sheikh et al. | Effect of supplementation of rumen protected methionine-lysine and choline on milk production in crossbred cows | |
| Lee | Effects of supplementing crystalline L-valine and L-isoleucine and a novel threonine biomass in reduced crude protein diets fed to broilers | |
| Nudiens | Opportunities of genetic potential of cross hybro-G broiler chicks using differently enriched feed | |
| SALEHPOUR et al. | MEASURING PLASMA GOSSYPOL IN COWS WERE FED DIFFERENT LEVELS WHOLE COTTONSEED | |
| Jayawickrama et al. | Feeding of Pigment Extracted Annatto Seed (Bixa orellana) Meal on Broiler Performance | |
| Abo–Egla et al. | EFFECT OF ADDING ORGANIC ACIDS TO DRINKING WATER OF YOUNG RABBITS ON THEIR PRODUCTIVE PERFORMANCE UP TO MARKETING AGE. |